4//SEC Filing
Crowley John J 4
Accession 0001847903-24-000114
CIK 0001847903other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:30 PM ET
Size
10.7 KB
Accession
0001847903-24-000114
Insider Transaction Report
Form 4
Crowley John J
Chief Financial Officer
Transactions
- Award
Share Option (right to buy)
2024-07-01+600,000→ 600,000 totalExercise: $8.80Exp: 2034-07-01→ Ordinary Shares (600,000 underlying)
Footnotes (2)
- [F1]25% of the shares subject to such option shall vest and become exercisable on July 1, 2025 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Documents
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0001587972
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 4:30 PM ET
- Size
- 10.7 KB